Join us to hear from Merck's Dr. Nick Kartsonis, and the history in addressing infectious disease and antimicrobial resistance. Dr. Nick Kartsonis will also be discussing the future in the area of C. diff. and some of the company's current treatments, including DIFICID and their ongoing research addressing CDI.
|